Controversial Sale of Nicotine Pouches in Federal Prisons Suspended

A Florida company established in May secured a unique deal to become the exclusive supplier of flavored nicotine pouches to the Bureau of Prisons’ 118 institutions. These pouches, branded “mindSHFT,” are not FDA-approved for sale in the U.S., as per FDA data. They are also not commercially available.

Following CBS News’s investigation into this deal, an anonymous federal employee raised concerns through complaints to the Justice Department’s inspector general and Attorney General Todd Blanche. Consequently, a senior prison official paused the arrangement, ordering all federal prisons to stop procuring the pouches until further notice.

This situation deserves immediate attention.

The whistleblower emphasized the Bureau of Prisons’ responsibility for ensuring the health and safety of federal prisoners. There is worry over the possible risks of distributing improperly authorized or contaminated products throughout federal prisons.

The Bureau of Prisons spokesperson stated that nicotine pouches were introduced in commissaries to address the trafficking of contraband tobacco and nicotine products within federal prisons. However, all purchasing has been suspended pending a review.

The pause came after consultations with the FDA and a legal review of current inventory, according to a source. No illnesses or adverse effects have been reported.

SHFT Enterprise Holdings LLC, incorporated in Florida one week after the BOP invited vendors for FDA-authorized nicotine pouches, supplied these products. The company’s domain was created on May 7, and amendments were made to allow the sale of nicotine pouches in commissaries, as detailed in BOP’s manual.

Procurement Process and Pricing

No formal request for proposals (RFP) was issued by BOP for a nicotine pouch provider, nor is there a signed contract with SHFT Enterprise Holdings. Nonetheless, on July 21, Adam Morrow, BOP’s trust fund chief, informed prisons that SHFT Enterprise Holdings LLC was the authorized vendor.

Orders were recommended at three tins per inmate to ensure availability. SHFT charged $6.99 per tin, while inmates paid $9.10 each. The products reportedly sold well where available.

Federal law prohibits the marketing and sale of non-FDA-authorized nicotine products. After legal consultation, BOP halted sales, and further purchasing pauses were instituted.

FDA experts emphasize that selling unauthorized products equates to selling “adulterated” goods. Without FDA approval, the product’s content and origins are uncertain.

Company Background

SHFT Enterprise Holdings claims their product is a healthier alternative to cigarettes, as noted on their website. However, FDA approval is not referenced in company communications or on packaging.

The FDA only authorizes two companies to sell nicotine pouches currently. Meanwhile, SHFT’s application status with the FDA is unclear.

SHFT’s connections trace back to Redcon1, a fitness supplement company formerly associated with Aaron Singerman, a convicted businessman and member of Mar-a-Lago. Despite shared business ties, no direct links to SHFT were found for Singerman.

Concerns and Impact

BOP staff expressed worry about selling nicotine pouches due to potential security and safety risks. Since 2014, tobacco-related products have been banned in commissaries, although this regulation doesn’t cover nicotine pouches.

Trust funds benefiting from commissary sales were reported to be profitable, despite initial losses unrelated to nicotine sales.

The complex network and the procurement process remain under scrutiny to safeguard health and safety within federal prisons.